213 related articles for article (PubMed ID: 34981978)
1. Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis.
Heckova E; Dal-Bianco A; Strasser B; Hangel GJ; Lipka A; Motyka S; Hingerl L; Rommer PS; Berger T; Hnilicová P; Kantorová E; Leutmezer F; Kurča E; Gruber S; Trattnig S; Bogner W
Radiology; 2022 Apr; 303(1):141-150. PubMed ID: 34981978
[TBL] [Abstract][Full Text] [Related]
2. Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
Loizou CP; Petroudi S; Seimenis I; Pantziaris M; Pattichis CS
J Neuroradiol; 2015 Apr; 42(2):99-114. PubMed ID: 24970463
[TBL] [Abstract][Full Text] [Related]
3. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI.
Treaba CA; Granberg TE; Sormani MP; Herranz E; Ouellette RA; Louapre C; Sloane JA; Kinkel RP; Mainero C
Radiology; 2019 Jun; 291(3):740-749. PubMed ID: 30964421
[TBL] [Abstract][Full Text] [Related]
5. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
[TBL] [Abstract][Full Text] [Related]
6. Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.
Pietroboni AM; Colombi A; Contarino VE; Russo FML; Conte G; Morabito A; Siggillino S; Carandini T; Fenoglio C; Arighi A; De Riz MA; Arcaro M; Sacchi L; Fumagalli GG; Bianchi AM; Triulzi F; Scarpini E; Galimberti D
Eur Radiol; 2023 Aug; 33(8):5368-5377. PubMed ID: 36562783
[TBL] [Abstract][Full Text] [Related]
7. Lesion-Specific Metabolic Alterations in Relapsing-Remitting Multiple Sclerosis Via 7 T Magnetic Resonance Spectroscopic Imaging.
Lipka A; Niess E; Dal-Bianco A; Hangel GJ; Rommer PS; Strasser B; Motyka S; Hingerl L; Berger T; Hnilicová P; Kantorová E; Leutmezer F; Kurča E; Gruber S; Trattnig S; Bogner W
Invest Radiol; 2023 Feb; 58(2):156-165. PubMed ID: 36094811
[TBL] [Abstract][Full Text] [Related]
8. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.
Chard DT; Griffin CM; McLean MA; Kapeller P; Kapoor R; Thompson AJ; Miller DH
Brain; 2002 Oct; 125(Pt 10):2342-52. PubMed ID: 12244090
[TBL] [Abstract][Full Text] [Related]
9. Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study.
Kapeller P; McLean MA; Griffin CM; Chard D; Parker GJ; Barker GJ; Thompson AJ; Miller DH
J Neurol; 2001 Feb; 248(2):131-8. PubMed ID: 11284131
[TBL] [Abstract][Full Text] [Related]
10. Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study.
Auer DP; Schirmer T; Heidenreich JO; Herzog J; Pütz B; Dichgans M
Neurology; 2001 Mar; 56(5):635-42. PubMed ID: 11245716
[TBL] [Abstract][Full Text] [Related]
11. Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients.
Chen X; Schädelin S; Lu PJ; Ocampo-Pineda M; Weigel M; Barakovic M; Ruberte E; Cagol A; Marechal B; Kober T; Kuhle J; Kappos L; Melie-Garcia L; Granziera C
Neuroimage Clin; 2023; 37():103349. PubMed ID: 36801600
[TBL] [Abstract][Full Text] [Related]
12. Normal appearing and diffusely abnormal white matter in patients with multiple sclerosis assessed with quantitative MR.
West J; Aalto A; Tisell A; Leinhard OD; Landtblom AM; Smedby Ö; Lundberg P
PLoS One; 2014; 9(4):e95161. PubMed ID: 24747946
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of normal appearing white matter in multiple sclerosis: comparison of diffusion magnetic resonance, magnetization transfer imaging and multivoxel magnetic resonance spectroscopy findings with expanded disability status scale.
Anik Y; Demirci A; Efendi H; Bulut SS; Celebi I; Komsuoglu S
Clin Neuroradiol; 2011 Nov; 21(4):207-15. PubMed ID: 21847666
[TBL] [Abstract][Full Text] [Related]
14. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
[TBL] [Abstract][Full Text] [Related]
15. The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study.
Dehmeshki J; Chard DT; Leary SM; Watt HC; Silver NC; Tofts PS; Thompson AJ; Miller DH
J Neurol; 2003 Jan; 250(1):67-74. PubMed ID: 12527995
[TBL] [Abstract][Full Text] [Related]
16. Spiral MRSI and tissue segmentation of normal-appearing white matter and white matter lesions in relapsing remitting multiple sclerosis patients
Al-Iedani O; Ribbons K; Gholizadeh N; Lechner-Scott J; Quadrelli S; Lea R; Andronesi O; Ramadan S
Magn Reson Imaging; 2020 Dec; 74():21-30. PubMed ID: 32898652
[TBL] [Abstract][Full Text] [Related]
17. Low choline concentrations in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
Gustafsson MC; Dahlqvist O; Jaworski J; Lundberg P; Landtblom AM
AJNR Am J Neuroradiol; 2007 Aug; 28(7):1306-12. PubMed ID: 17698533
[TBL] [Abstract][Full Text] [Related]
18. Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.
Beer A; Biberacher V; Schmidt P; Righart R; Buck D; Berthele A; Kirschke J; Zimmer C; Hemmer B; Mühlau M
J Neurol; 2016 Aug; 263(8):1495-502. PubMed ID: 27178000
[TBL] [Abstract][Full Text] [Related]
19. Cerebral white matter blood flow and energy metabolism in multiple sclerosis.
Steen C; D'haeseleer M; Hoogduin JM; Fierens Y; Cambron M; Mostert JP; Heersema DJ; Koch MW; De Keyser J
Mult Scler; 2013 Sep; 19(10):1282-9. PubMed ID: 23428956
[TBL] [Abstract][Full Text] [Related]
20. Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters.
Gasperini C; Horsfield MA; Thorpe JW; Kidd D; Barker GJ; Tofts PS; MacManus DG; Thompson AJ; Miller DH; McDonald WI
J Magn Reson Imaging; 1996; 6(4):580-4. PubMed ID: 8835949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
